Correction to “Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTrace Elements in Health · Autophagy in Disease and Therapy · Nephrotoxicity and Medicinal Plants
L. Tang, C. Zhao, J. Zhang, T. Dong, H. Chen, T. Wei, J. Wang, and W. Yang, “Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson’s Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification,” Mediators of Inflammation, 2023, https://doi.org/10.1155/2023/3236911.
In the article, there are errors in Figure 3c. Specifically:
- •The Gandoufumu High‐dose and Middle‐dose panels in the last row of the Sirius Red staining images are duplicated.
- •The Normal and Penicillamine panels in the last row of Sirius Red staining were 100x, whereas the figure legend specifies 400x.
The correct Figure 3 is shown below:
We apologize for these errors.